New Biocompatible β‐Phosphorylated Linear Nitrones Targeting Mitochondria: Protective Effect in Apoptotic Cells

Authors: Culcasi, Marcel, Delehedde, Caroline, Esgulian, Mathieu, Cassien, Mathieu, Chocry, Mathieu, Rockenbauer, Antal, Pietri, Sylvia, Thétiot‐Laurent, Sophie

Source: Chembiochem. 24(8)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181649833.0x000001&indx=1&recIds=ETOCvdc_100181649833.0x000001

The NADPH Oxidase Family and Its Inhibitors

Authors: Chocry, Mathieu, Leloup, Ludovic

Source: Antioxidants & redox signaling. 33(5):332-353

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100150480218.0x000001&indx=1&recIds=ETOCvdc_100150480218.0x000001

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer.

Authors: Chocry, Mathieu¹ (AUTHOR), Leloup, Ludovic¹ (AUTHOR) ludovic.leloup@univ-amu.fr, Parat, Fabrice¹ (AUTHOR), Messé, Mélissa² (AUTHOR), Pagano, Alessandra¹ (AUTHOR), Kovacic, Hervé¹ (AUTHOR)

Source: Cancers. Dec2022, Vol. 14 Issue 23, p5894. 17p.

Subject Terms: *IN vitro studies, *DRUG efficacy, *IN vivo studies, *CANCER chemotherapy, *DEOXYCYTIDINE, *APOPTOSIS, *ANTINEOPLASTIC agents, *COLORECTAL cancer, *CANCER patients, *TREATMENT effectiveness, *ORGANOPLATINUM compounds, *TREATMENT failure, *CELLULAR signal transduction, *CELL proliferation, *TRANSFERASES, *OXALIPLATIN, *ALTERNATIVE medicine, *MITOGEN-activated protein kinases, *REACTIVE oxygen species, *DRUG resistance in cancer cells, *CYTOTOXINS

Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem‐Like Cell Fate in an Oxygen‐Dependent Manner

Authors: Soubéran, Aurélie, Cappaï, Jessica, Chocry, Mathieu, Nuccio, Christopher, Raujol, Julie, Colin, Carole, Lafitte, Daniel, Kovacic, Hervé, Quillien, Véronique, Baeza‐Kallee, Nathalie, Rougon, Geneviève, Figarella‐Branger, Dominique, Tchoghandjian, Aurélie

Source: Stem cells. 37(6):731-742

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100086946188.0x000001&indx=1&recIds=ETOCvdc_100086946188.0x000001

This result is not displayed to guests.
Login for full access.

Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile.

Authors: Mattei, Jean Camille, Bouvier-Labit, Corinne, Barets, Doriane, Macagno, Nicolas, Chocry, Mathieu, Chibon, Frédéric, Morando, Philippe, Rochwerger, Richard Alexandre, Duffaud, Florence, Olschwang, Sylviane, Salas, Sébastien, Jiguet-Jiglaire, Carine

Source: Cancers; Mar2020, Vol. 12 Issue 3, p583, 1p

Subject Terms: ANTINEOPLASTIC agents, CELL lines, CELL physiology, CELLULAR signal transduction, COMBINATION drug therapy, DOXORUBICIN, DRUG resistance, GENE expression, LIPOSARCOMA, MESSENGER RNA, METASTASIS, PHOSPHOTRANSFERASES, SARCOMA, SURVIVAL analysis (Biometry), GENE expression profiling, PROTEIN kinase inhibitors